SOURCE: Dynavax Technologies

Dynavax Technologies

February 17, 2016 07:00 ET

Dynavax to Participate in 2016 RBC Capital Markets Global Healthcare Conference

BERKELEY, CA--(Marketwired - February 17, 2016) -  Dynavax Technologies Corporation (NASDAQ: DVAX) today announced that Eddie Gray, Dynavax's chief executive officer, will participate in a fireside chat at the RBC Capital Markets 2016 Global Healthcare Conference next week in New York, NY. The session will be webcast live and will occur on Wednesday, February 24, 2016 at 3:35 p.m. EST.

The live or replayed versions of the webcast will be available by visiting the "Investors" section of the Dynavax website.

About Dynavax

Dynavax, a clinical-stage biopharmaceutical company, discovers and develops novel vaccines and therapeutics in the areas of infectious diseases and oncology. Dynavax's lead product candidates are HEPLISAV-B™, a Phase 3 investigational adult hepatitis B vaccine and SD-101, an investigational cancer immunotherapeutic currently in several Phase 1/2 studies. For more information, visit

Contact Information

  • Contact:
    Michael Ostrach
    Chief Financial Officer
    Email contact